Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73
Remco van Doorn, Willem H. Zoutman, Remco Dijkman, et al.
Journal of Clinical Oncology (2005) Vol. 23, Iss. 17, pp. 3886-3896
Open Access | Times Cited: 227

Showing 26-50 of 227 citing articles:

A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome
Oliver Hampton, Petra den Hollander, Christopher A. Miller, et al.
Genome Research (2008) Vol. 19, Iss. 2, pp. 167-177
Open Access | Times Cited: 130
DNA methylation and apoptosis
Gopal Gopisetty, K.I. Ramachandran, R. Singal
Molecular Immunology (2006) Vol. 43, Iss. 11, pp. 1729-1740
Closed Access | Times Cited: 116
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment
Vadim Yuferov, Orna Levran, Dmitri Proudnikov, et al.
Annals of the New York Academy of Sciences (2010) Vol. 1187, Iss. 1, pp. 184-207
Open Access | Times Cited: 108
miRNA expression profiling of mycosis fungoides
Marloes S. van Kester, Erica Ballabio, Marchina F. Benner, et al.
Molecular Oncology (2011) Vol. 5, Iss. 3, pp. 273-280
Open Access | Times Cited: 95
CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
Elodie Laharanne, Edith Chevret, Yamina Idrissi, et al.
Modern Pathology (2010) Vol. 23, Iss. 4, pp. 547-558
Open Access | Times Cited: 91
A Meta-Analysis of Gene Expression Data Identifies a Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides
Marloes S. van Kester, Martin K. Borg, Willem H. Zoutman, et al.
Journal of Investigative Dermatology (2012) Vol. 132, Iss. 8, pp. 2050-2059
Open Access | Times Cited: 86
Thrombospondin-4 in tissue remodeling
Olga Stenina‐Adognravi, Edward F. Plow
Matrix Biology (2017) Vol. 75-76, pp. 300-313
Open Access | Times Cited: 81
Epigenetic biomarkers in skin cancer
Edward S. Greenberg, Kelly K. Chong, Kelly Huynh, et al.
Cancer Letters (2012) Vol. 342, Iss. 2, pp. 170-177
Open Access | Times Cited: 79
The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
Ivan V. Litvinov, Elena Netchiporouk, Brendan Cordeiro, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 12, pp. 2820-2829
Open Access | Times Cited: 77
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
Urvi A. Shah, Elaine Y. Chung, Orsi Giricz, et al.
Blood (2018) Vol. 132, Iss. 14, pp. 1507-1518
Open Access | Times Cited: 76
Receptor-type protein tyrosine phosphatases in cancer
Yu Du, Jennifer R. Grandis
Chinese Journal of Cancer (2014) Vol. 34, Iss. 2, pp. 61-69
Open Access | Times Cited: 73
MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ulrik Ralfkiær, Lise M. Lindahl, Thomas Litman, et al.
PubMed (2014) Vol. 34, Iss. 12, pp. 7207-17
Closed Access | Times Cited: 70
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
Regulation of the DNA damage response by ubiquitin conjugation
Kerstin Brinkmann, Michael J. Schell, Thorsten Hoppe, et al.
Frontiers in Genetics (2015) Vol. 6
Open Access | Times Cited: 65
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
Sean Whittaker, Francine M. Foss
Cancer Treatment Reviews (2007) Vol. 33, Iss. 2, pp. 146-160
Open Access | Times Cited: 91
Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: An emphasis on fetal-based adult diseases
S HO, Wan‐Yee Tang
Reproductive Toxicology (2007) Vol. 23, Iss. 3, pp. 267-282
Open Access | Times Cited: 91
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
Omar Khan, Nicholas B. La Thangue
Nature Clinical Practice Oncology (2008) Vol. 5, Iss. 12, pp. 714-726
Closed Access | Times Cited: 86
Protein tyrosine phosphatases: functional inferences from mouse models and human diseases
Wiljan Hendriks, Ari Elson, Sheila Harroch, et al.
FEBS Journal (2008) Vol. 275, Iss. 5, pp. 816-830
Open Access | Times Cited: 82
Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides
Rocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Journal of Investigative Dermatology (2009) Vol. 130, Iss. 4, pp. 1126-1135
Open Access | Times Cited: 78
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade
Michael K. Kießling, Patrick A. Oberholzer, Chandrani Mondal, et al.
Blood (2011) Vol. 117, Iss. 8, pp. 2433-2440
Open Access | Times Cited: 75
Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2011) Vol. 86, Iss. 11, pp. 928-948
Open Access | Times Cited: 71
Utility of DNA methylation markers for diagnosing cancer
Sohail A. Qureshi, Muhammed Umair Bashir, Ahmed Yaqinuddin
International Journal of Surgery (2010) Vol. 8, Iss. 3, pp. 194-198
Open Access | Times Cited: 69
Hydralazine–valproate: a repositioned drug combination for the epigenetic therapy of cancer
Alfonso Dueñas‐González, Jaime Coronel, Lucely Cetina, et al.
Expert Opinion on Drug Metabolism & Toxicology (2014) Vol. 10, Iss. 10, pp. 1433-1444
Closed Access | Times Cited: 59
Tumor microenvironment in mycosis fungoides and Sézary syndrome
Belén Rubio González, Jasmine Zain, Steven T. Rosen, et al.
Current Opinion in Oncology (2015) Vol. 28, Iss. 1, pp. 88-96
Closed Access | Times Cited: 58
Epigenetics and Oncology
Padmaja Mummaneni, Stacy S. Shord
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2014) Vol. 34, Iss. 5, pp. 495-505
Closed Access | Times Cited: 55

Scroll to top